Figure 4.
(A) Proteome-wide degradation selectivity of TMX-2172 at a dose of 250 nM in OVCAR8 after 6 hours treatment. (B) Immunoblot analysis of CDKs in OVCAR8 cells treated with TMX-2172 for 6 hours.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.